Chloé Couat

Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants

J. Izopet, N. Kamar, F. Abravanel, 2021, Annals of Internal Medicine.

Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated with Belatacept.

J. Izopet, L. Chatenoud, N. Kamar, 2021, Transplantation.

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

J. Izopet, N. Kamar, F. Abravanel, 2021, The New England journal of medicine.

Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant

J. Izopet, R. Romieu-Mourez, N. Kamar, 2021, JAMA network open.

Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients

J. Izopet, N. Kamar, F. Abravanel, 2021, American Journal of Transplantation.

Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine

J. Izopet, R. Romieu-Mourez, N. Kamar, 2022, Vaccines.

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients

J. Izopet, M. Nogier, N. Kamar, 2022, American Journal of Transplantation.